Mutual of Omaha Life Insurance Fit Review for Epilepsy and Seizure Disorders

Research Snapshot

Why Mutual of Omaha Qualified for This Study

Questions This Section Answers

• Is Mutual of Omaha a good choice for life insurance for epilepsy and seizure disorders?
• How many AI platforms named Mutual of Omaha for epilepsy life insurance, and at what average rank?

Mutual of Omaha qualified because every included platform named it during ranking discovery, and because its guaranteed-issue whole life product is directly relevant to the underwriting problem this use case creates. It was named by anthropic, deepseek, google, grok, kimi, openai, and perplexity — 7 of 7 included platforms, a 100% platform share ^[1].

Its listed ranks ranged from 1 (openai) to 8 (perplexity), producing an average listed rank of 3.86. The spread matters: platforms that ranked it first emphasized guaranteed acceptance for applicants with frequent or recent seizures, while the platform that ranked it lowest treated it as a mixed fit because its simplified-issue and term products still depend on seizure history.

Fit ratings were not unanimous. Six platforms rated Mutual of Omaha good or strong for this use case; perplexity rated it mixed. Google rated it strong, describing a "complete underwriting spectrum" from no-health-question policies to fully underwritten term. That rating spread is itself a finding: the carrier's fit depends heavily on which product tier a buyer is eligible for.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Epilepsy and Seizure Disorders

Questions This Section Answers

• Which Mutual of Omaha plan should a buyer with epilepsy choose if they need guaranteed approval with no health questions?
• Is Mutual of Omaha's Guaranteed Whole Life or Living Promise plan better for someone with frequent seizures?

The most relevant offering is Mutual of Omaha's Guaranteed Whole life insurance, underwritten by United of Omaha Life Insurance Company outside New York ^[8]. It is advertised as requiring no medical exam and no health questions, which means a seizure disorder does not by itself prevent acceptance if the applicant meets the product's age and application requirements ^[10].

The second relevant path is Living Promise Whole Life Insurance, a simplified-issue final-expense product that does ask health questions and can be declined ^[11]. Platforms describe it as tiered: a Level Benefit plan with day-one coverage for applicants whose condition is well controlled, and a Graded Benefit plan with a waiting period for those with more frequent seizures ^[13].

Product naming is inconsistent across sources and this is a real buyer risk. Platforms referred to "Guaranteed Acceptance Whole Life," "Guaranteed Issue Whole Life," "Living Promise," and "United of Omaha Guaranteed Whole Life" — sometimes as separate products, sometimes interchangeably (openai, anthropic, deepseek, grok, kimi, google, perplexity). OpenAI's own uncertainty note states that the reviewed current consumer materials consistently describe the relevant offering as Guaranteed Whole Life, but that exact branding and policy form may vary by state and distribution channel. Buyers should confirm which product they are actually being quoted.

What the AI Platforms Agreed About

Questions This Section Answers

• Do all AI platforms agree that Mutual of Omaha accepts applicants with epilepsy without a medical exam?
• What do AI platforms agree is the biggest drawback of Mutual of Omaha guaranteed issue coverage for epilepsy?

Agreement was strong on four points.

First, the guaranteed-issue product does not use medical underwriting. Mutual of Omaha states its guaranteed whole life product is not subject to medical underwriting and guarantees acceptance ^[16]. Independent epilepsy guidance from Policygenius, cited by three platforms, names Mutual of Omaha's guaranteed issue policy as a fit for applicants with recent or frequent seizures ^[19].

Second, the two-year limited-benefit period is real and material. For a nonaccidental death during the first two years, the beneficiary receives 110% of premiums paid; accidental death pays the full face amount from the beginning, and the full benefit applies after two years ^[22].

Third, coverage is small and final-expense oriented. The advertised guaranteed whole life benefit range is $2,000–$25,000, with a $5,000 minimum stated for Washington ^[27]. Several platforms noted that agent-channel Living Promise coverage can reach $40,000 ^[30].

Fourth, eligibility is age-limited. Guaranteed acceptance is described as ages 45–85, with New York stated as ages 50–75 ^[33].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• What is unclear about Mutual of Omaha's underwriting rules for controlled epilepsy?
• Does Mutual of Omaha's guaranteed issue product have different age limits depending on the source?

Platforms disagreed or were uncertain on five points, and buyers should treat each as unresolved.

Issue ages. A Mutual of Omaha producer brochure states issue ages 18–70 for a guaranteed-issue product, while third-party sources describe guaranteed-issue final expense as available only to older buyers ^[36]. Perplexity explicitly flagged this conflict. The exact consumer-facing age range is unclear from the sources checked.

Seizure-specific underwriting rules. No platform located official Mutual of Omaha underwriting documentation specifying how seizure type, frequency, time since last seizure, medications, treatment compliance, neurological evaluation, or driving restrictions are weighted for its medically underwritten products (openai, anthropic, deepseek, kimi, perplexity). One platform cited a Mutual of Omaha underwriting guide stating standard rating is possible after one year if epilepsy is controlled with medication and no seizures occur for one year, with Table 2–4 ratings for 2+ years seizure-free ^[39]. Another cited a producer document listing seizure disorders as an impairment requiring APS review ^[41]. These are platform-reported and not confirmed on Mutual of Omaha consumer pages.

Pricing. No epilepsy-specific premiums, rate table, or guaranteed-issue quote was publicly available in the reviewed materials (openai, deepseek, perplexity). Independent reviews cite $20–$250 per month for $10,000–$25,000 of final-expense coverage, but these are third-party estimates, not Mutual of Omaha quotes ^[42]. Google cited a $6.38 monthly starting premium for a $2,000 policy for a 45-year-old female ^[38].

MIB and prescription checks. One source states Living Promise checks MIB records; others do not mention it ^[44]. Third-party agent guidance describes Living Promise underwriting as potentially involving build chart review, MIB, prescription checks, medical data checks, and a phone interview ^[45].

Underwriting insurer by state. OpenAI noted that reviewed materials state different New York underwriting arrangements from the nationwide United of Omaha arrangement. Mutual of Omaha's own disclosure language on other product lines confirms this pattern: United of Omaha is licensed nationwide except New York, where Mutual of Omaha Insurance Company underwrites (official:C2, official:C3).

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• Does Mutual of Omaha's guaranteed whole life policy pay the full death benefit if the insured dies from a seizure in the first two years?
• Can a buyer with epilepsy get day-one coverage through Mutual of Omaha's Living Promise plan?

The features most relevant to this use case are guaranteed acceptance, the graded death benefit, level premiums, and the tiered underwriting path.

Guaranteed acceptance. The guaranteed whole life product requires no medical exam or health-risk evaluation, and Mutual of Omaha's no-exam materials distinguish guaranteed products from simplified-issue products, which may still use health questionnaires, prescription history, driving records, lifestyle data, and other underwriting information ^[46].

Graded death benefit. Natural-cause deaths in the first two years pay 110% of premiums; accidental deaths pay the full face amount from day one; full benefit applies after two years ^[48]. This is the single most important feature for a buyer with epilepsy, because a natural-cause death in the early policy years produces a limited payout.

Level premiums. Mutual of Omaha states whole life premiums are guaranteed not to increase and coverage remains in force while premiums are paid as required ^[53].

Tiered underwriting. Platforms describe a spectrum: guaranteed acceptance for the highest-risk applicants, Living Promise simplified issue with level or graded tiers based on seizure control and medication compliance, and fully underwritten term or whole life for well-controlled cases ^[55].

Cash value and loans. One platform reported policy loans available against cash value at a 7.4% rate and surrender value available at age 120 (anthropic). Google reported cash value can be borrowed against after three years in force (google). OpenAI stated cash-value, surrender, loan, rider, lapse, and reinstatement economics were not fully verified from reviewed public pages. Treat these as platform-reported and unverified.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Mutual of Omaha guaranteed whole life cost per month for a buyer with epilepsy?
• Are there cancellation fees or a free-look period on Mutual of Omaha's guaranteed issue policy?

No epilepsy-specific premiums, rate table, commission, or guaranteed-issue quote was publicly available in the reviewed materials (openai, deepseek, perplexity). Mutual of Omaha states premiums depend on factors including age, gender, and death-benefit amount, and that guaranteed whole life premiums are level and do not increase ^[61].

Independent third-party estimates, which are not Mutual of Omaha quotes:

Guaranteed acceptance is consistently more expensive than standard final-expense coverage for the same age and amount ^[62]. That is the expected tradeoff for skipping underwriting.

Contract terms reported across platforms: coverage remains in force only while required premiums are paid on time; a two-year limited-benefit provision applies to nonaccidental death on the guaranteed-issue product; no fixed-term contract period applies to whole life coverage (openai). A suicide exclusion applies for two years on the quoted product page, with state variations noted for MN, ND, and NY ^[63]. Free-look periods are state-mandated, typically 10–30 days from policy delivery (kimi). No separate application fee or policy fee was identified in reviewed public materials, though state-specific policy, rider, billing, or reinstatement charges were not ruled out (openai).

Best Suited For

Questions This Section Answers

• Who is Mutual of Omaha's guaranteed whole life policy actually designed for among epilepsy applicants?
• Is Mutual of Omaha a good fit for an older buyer with frequent seizures who needs final expense coverage?

Mutual of Omaha is best suited for applicants age 45–85 (50–75 in New York) who need modest permanent final-expense coverage and whose epilepsy or seizure history makes traditional underwriting uncertain or unavailable ^[64].

Platforms consistently identified these buyer profiles:

• Applicants with recent, frequent, or uncontrolled seizures who cannot qualify for traditional underwriting ^[67].
• Consumers seeking fixed premiums and a small permanent death benefit for burial, funeral, final bills, or debt repayment ^[70].
• Applicants with stable seizure control who can answer health questions and may qualify for Living Promise level or graded tiers ^[72].
• Buyers who want no medical exam and no health questions at application and accept a graded death benefit and higher premium per dollar of coverage (deepseek, perplexity).

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Mutual of Omaha for life insurance with epilepsy?
• Is Mutual of Omaha a poor fit for a younger buyer with epilepsy who needs large coverage?

Mutual of Omaha is probably not the best fit for four buyer profiles.

Applicants younger than the product's stated eligibility range. Guaranteed and final-expense policies are described as available only to ages 45–85 (50–75 in New York), excluding younger adults with epilepsy ^[74]. One producer brochure conflicts on this point, stating issue ages 18–70 ^[77], so a younger buyer should verify directly rather than assume ineligibility.

Consumers needing substantial income-replacement, mortgage, or family-protection coverage. The published maximum of $25,000 makes the guaranteed-issue product unsuitable by itself for most substantial income-replacement or estate-planning needs ^[78].

Applicants whose seizures are well controlled. Buyers who may qualify for less expensive simplified-issue or fully underwritten coverage should price those first, because guaranteed-issue coverage can be less cost-efficient when the applicant qualifies for standard or rated insurance ^[81].

Buyers who need a full day-one natural-death benefit. The two-year limited-benefit period creates an early-claim risk that a buyer needing immediate full protection should weigh carefully ^[82].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Mutual of Omaha for a buyer with well-controlled epilepsy who needs larger coverage?
• When should a buyer with epilepsy skip guaranteed issue and apply for fully underwritten term life instead?

Another option may be better in five situations, based on platform-reported alternatives.

Well-controlled epilepsy. If seizures have been controlled for a meaningful period, the buyer can pursue simplified-issue or fully underwritten term, whole life, or universal life coverage, which may provide more coverage or better value ^[84]. Platforms named Legal & General America, Banner/William Penn, and Prudential as carriers that may offer standard-to-table ratings for seizure-free applicants (kimi).

Coverage above final-expense limits. Buyers needing $250,000+ or income-replacement coverage should look at fully underwritten term or high-risk specialists and impaired-risk brokers (kimi, anthropic).

Younger applicants. Buyers under 45 needing guaranteed issue should compare carriers that accommodate younger ages (google, anthropic).

Lower cost per dollar. Competitors may offer better rates for stable seizure control, and platforms recommended comparing quotes from other final-expense carriers such as Foresters, AIG, Royal Neighbors, Gerber Life, and Colonial Penn (anthropic, kimi).

Shorter or no waiting period. Some competing final-expense carriers may offer level coverage with no waiting period for controlled seizures ^[85].

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with Mutual of Omaha before signing a guaranteed whole life contract?
• How can a buyer verify which Mutual of Omaha product they are actually being quoted?

Platforms converged on a consistent verification list. Buyers should confirm:

1. Which product is being quoted — guaranteed-issue whole life or simplified-issue Living Promise — and whether it requires answering health questions (deepseek, perplexity).
2. Eligibility for guaranteed whole life in the buyer's state and at the buyer's exact age, including the New York age difference (openai, anthropic).
3. The exact premium, payment mode, face amount, cash value, surrender value, and total projected premiums (openai, anthropic).
4. Whether the policy pays 110% of premiums for every nonaccidental death during the first two years, and any state-specific variations or exclusions ^[86].
5. How seizure type, frequency, last seizure, medications, neurologist records, compliance, and driving restrictions would affect approval and rate class on simplified-issue or fully underwritten products (openai, anthropic, perplexity).
6. Whether prescription history review or MIB record check will be performed and what conditions might trigger a denial or downgrade to graded benefit ^[87].
7. Whether the buyer can upgrade from graded to level benefit after seizures have been stable for a period, or if the tier is locked at issue (anthropic).
8. Who the actual underwriting insurer is in the buyer's state, and which policy form and state disclosures govern (openai, perplexity).
9. What happens if premiums are missed, the policy lapses, or the buyer later wants to reduce, surrender, or borrow against the policy (openai).
10. Whether competing quotes from insurers that publish or routinely handle epilepsy-specific underwriting would beat the guaranteed-issue offer (openai, kimi).

Final AI Consensus Verdict

Mutual of Omaha is a good, but narrowly useful, fit for a consumer with epilepsy or another seizure disorder who needs small guaranteed-issue final-expense coverage and cannot reasonably qualify for medically underwritten insurance. All 7 included platforms named it during ranking discovery, and 6 of 7 rated it good or strong for this use case.

It is not the best default choice for younger applicants, larger coverage needs, or buyers with well-controlled seizures who may obtain broader day-one coverage at a lower cost through simplified or full underwriting. The two-year limited-benefit period, the modest coverage ceiling, and the age restrictions are the three limitations platforms repeated most often.

The clearest consensus finding is structural: Mutual of Omaha's value for this use case depends entirely on which product tier a buyer is eligible for. Buyers who can qualify for Living Promise level benefit or fully underwritten coverage should price those paths first. Buyers who cannot should treat guaranteed whole life as a fallback that trades cost efficiency and early-year benefit for guaranteed approval.

How This Review Was Produced

This review evaluates Mutual of Omaha only for the Life Insurance for Epilepsy and Seizure Disorders use case. It is not a broad company review. It draws on fit-research responses from 7 AI platforms — anthropic, deepseek, google, grok, kimi, openai, and perplexity — each of which evaluated Mutual of Omaha against the same buyer prompt and returned structured findings, citations, pricing notes, limitations, and a fit rating.

The ranking stage counted platforms that named Mutual of Omaha during discovery. All 7 did. Fit ratings were assigned by each platform independently: google rated it strong; anthropic, deepseek, grok, kimi, and openai rated it good; perplexity rated it mixed.

This article is part of a broader Life Insurance for Epilepsy and Seizure Disorders consensus index covering multiple carriers. For general background on the product category, see the life insurance directory.

Methodology Limitations

Several limitations apply to this review.

Platform-reported evidence. Citations are platform-reported evidence, not independently verified facts. The supplied URLs were collected from platform responses and were not independently validated by the writer stage.

Research date discrepancy. The authoritative run research date is 2026-09-22. Deepseek's platform-reported research date is 2026-06-13, which differs from the run date. Platform-reported dates are provenance metadata and do not independently prove freshness.

No-search model. Deepseek's research capability record shows search_enabled: false. Its claims require explicit verification before being described as current facts.

Unresolved conflicts. Product naming, issue ages, face-amount caps, and pricing vary across sources. This review describes those conflicts rather than resolving them. Buyers should verify specifics directly with Mutual of Omaha or a licensed broker.

Missing pricing. No epilepsy-specific premiums or guaranteed-issue quotes were publicly available in the reviewed materials. All pricing figures in this review are either third-party estimates or company starting-premium examples, not personalized quotes.

No independent verification of underwriting outcomes. No platform located official Mutual of Omaha documentation specifying how seizure type, frequency, time since last seizure, medications, treatment compliance, neurological evaluation, or driving restrictions affect its medically underwritten products.

AI agreement is not quality proof. That multiple platforms named Mutual of Omaha does not prove the product is superior. It reflects consistent retrieval and recognition across models.